MS MBA - Milestone Scientific Vice Finance
| MLSS Stock | USD 0.29 0.02 6.45% |
Executive
MS MBA is Vice Finance of Milestone Scientific
| Phone | 973 535 2717 |
| Web | https://www.milestonescientific.com |
Milestone Scientific Management Efficiency
The company has return on total asset (ROA) of (0.4234) % which means that it has lost $0.4234 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3647) %, meaning that it created substantial loss on money invested by shareholders. Milestone Scientific's management efficiency ratios could be used to measure how well Milestone Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Carlos Carillo | SAB Biotherapeutics | N/A | |
| Joseph Traut | Precision Optics, | N/A | |
| Catherine DeRose | SAB Biotherapeutics | N/A | |
| Mark CPA | Apimeds Pharmaceuticals US, | 67 | |
| Clay Schwabe | Precision Optics, | N/A | |
| Jonathan Naft | Myomo Inc | N/A | |
| Galina Shtivelman | Myomo Inc | N/A | |
| Brian Peters | Apimeds Pharmaceuticals US, | N/A | |
| Erick Frim | Apimeds Pharmaceuticals US, | 67 | |
| James Green | Harvard Bioscience | 67 | |
| Susan PH | Apimeds Pharmaceuticals US, | 75 | |
| MD MBA | SAB Biotherapeutics | 53 | |
| Captain Yadav | Apimeds Pharmaceuticals US, | N/A | |
| Dr MSc | SAB Biotherapeutics | N/A | |
| John JD | Harvard Bioscience | 64 | |
| Amardeep Singh | Apimeds Pharmaceuticals US, | N/A | |
| Patrick Ryan | Nutriband | 38 | |
| Lori Packer | Harvard Bioscience | N/A | |
| Alan Smith | Nutriband | 59 | |
| Mark Conley | SAB Biotherapeutics | N/A | |
| Susana Salgar | India Globalization Capital | N/A | |
Management Performance
| Return On Equity | -1.36 | ||||
| Return On Asset | -0.42 |
Milestone Scientific Leadership Team
Elected by the shareholders, the Milestone Scientific's board of directors comprises two types of representatives: Milestone Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Milestone. The board's role is to monitor Milestone Scientific's management team and ensure that shareholders' interests are well served. Milestone Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Milestone Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James JD, Senior Development | ||
| Jan Haverhals, President Director | ||
| MS MBA, Vice Finance | ||
| James McAvinn, Senior Vice President - Sales & Marketing | ||
| Jason Papes, Senior Marketing | ||
| Leonard Osser, CEO and Director | ||
| Andy Molnar, Senior Dental | ||
| Keisha Harcum, Controller | ||
| Neal CFA, Chairman CEO | ||
| Eric Hines, President Officer |
Milestone Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Milestone Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.36 | ||||
| Return On Asset | -0.42 | ||||
| Profit Margin | (0.75) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 22.51 M | ||||
| Shares Outstanding | 78.63 M | ||||
| Shares Owned By Insiders | 22.60 % | ||||
| Shares Owned By Institutions | 5.66 % | ||||
| Number Of Shares Shorted | 879 K | ||||
| Price To Earning | (6.39) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.